期刊文献+

HPV16型E7重组蛋白的表达及其多克隆抗体的制备 被引量:7

Expression of HPV16 E7 protein and preparation of its polyclonal antibody
下载PDF
导出
摘要 目的制备人乳头瘤病毒(HPV)16型E7原核表达蛋白及其多克隆抗体。方法用PCR方法从宫颈癌组织中扩增HPV16 E7基因,克隆至pET21a(+)载体并构建pET21a(+)/HPV16 E7重组质粒,测序鉴定;将重组质粒转化至大肠杆菌BL21(DE3),经异丙基硫代-β-D-硫代吡喃半乳糖苷(IPTG)诱导后表达重组蛋白,用Ni-NTA亲和层析法纯化并经SDS-PAGE及Western blot分析鉴定;纯化的HPV16 E7重组蛋白免疫日本大耳白兔制备多克隆抗体,用ELISA检测多克隆抗体的效价,并用Western blot法及免疫荧光技术分析多克隆抗体的特异性。结果 HPV16 E7重组蛋白可通过原核表达系统进行表达和纯化;通过兔免疫后可制备特异性的多克隆IgG抗体,效价达1∶30 000;经Western blot法和免疫荧光染色结果证实兔多克隆抗体可特异性识别HPV16 E7蛋白。结论成功进行了HPV16 E7原核表达并制备了HPV16 E7兔多克隆抗体。 Objective To prepare a prokaryotic expression vector carrying E7 protein of human papillomavirus (HPV) type 16 and a polyclonal antibody against it. Methods The HPV16 E7 gene was amplified by PCR from the tissue samples of cervical cancer and cloned into the pET21a (+) prokaryotic expression vector. The constructed pET21a (+)/HPV16 E7 recombinant plasmid was transformed into E. coli BL21 ( DE3 ) and induced by isopropyl beta-D-l-thiogalactopyranoside (IPTG). The recombinant protein of HPVI6 E? was purified by Ni-NTA affinity chromatography and confirmed by SDS-PAGE and Western blot analysis. To prepare the polyclonal antibody, the rabbits were immunized with the purified recombinant protein HPVl6 E7. The titers of specific antibodies were detected by ELISA, The specificity activity was further detected by Western blotting and immunofluorescence analysis. Results HPV16 157 recombinant protein was expressed and purified in the prokaryotic expression system, The polyclonal antibodies were produced in the rabbits immunized with the recombinant protein. The titer of specific antibodies was up to 1:30 000. Western blotting and immunofluorescence analysis indicated that the polyclonal antibody could specifically recognize the HPV16 E7 protein. Conclusion HPV16 E7 recombinant protein was successfully expressed and its polyclonal antibody was prepared.
出处 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2014年第2期167-170,175,共5页 Chinese Journal of Cellular and Molecular Immunology
基金 国家自然科学基金(81172463)
关键词 人乳头瘤病毒 E7蛋白 多克隆抗体 human papillomavirus E7 protein polyclonal antibody
  • 相关文献

参考文献16

  • 1Bosch FX,Manos MM,Mu(n)z N. Prevalence of human papillomavirus in cervical cancer:a worldwide perspective.International biological study on cervical cancer (1BSCC) study group[J].{H}JOURNAL OF THE NATIONAL CANCER INSTITUTE,1995,(11):796-802.
  • 2Kaewprag J,Umnajvijit W,Ngamkham J. HPV16 Oncoproteins promote cervical cancer invasiveness by upregulating specific matrix metalloproteinases[J].PLoS One,2013,(8):e71611.
  • 3Münger K,Basile JR,Duensing S. Biological activities and molecular targets of the human papillomavirus E7 oncoprotein[J].{H}ONCOGENE,2001,(54):7888-7898.
  • 4Demurtas OC,Massa S,Ferrante P. A chlamydomonasderived human papillomavirus 16 e7 vaccine induces specific tumor protection[J].PLoS One,2013,(4):e61473.
  • 5Mu B,Yang JL,Gou LT. Polydonal rabbit anti-murine plasmacytoma cell globulins induce myeloma cells apoptosis and inhibit tumour growth in mice[J].{H}APOPTOSIS,2011,(4):370-381.
  • 6谭伟峰,王兰兰,李琦,罗阳,那达翔,马壮,王露.人类新基因CTRP4的原核表达及多克隆抗体的制备[J].细胞与分子免疫学杂志,2012,28(6):614-617. 被引量:6
  • 7Wick DA,Webb JR. A novel,broad spectrum therapeutic HPV vaccine targeting the E7 proteins of HPV16,18,31,45 and 52 that elicits potent E7-specific CD8T cell immunity and regression of large,established,E7-expressing TC-1 tumors[J].{H}VACCINE,2011,(44):7857-7866.
  • 8Fan X,Liu Y,Heilman SA. Human papillomavirus E7 induces rereplication in response to DNA damage[J].{H}Journal of Virology,2013,(2):1200-1210.
  • 9Wieking BG,Vermeer DW,Spanos WC. A non-oncogenic HPV 16 E6/E7 vaccine enhances treatment of HPV expressing tumors[J].{H}Cancer Gene Therapy,2012,(10):667-674.
  • 10Ca L,A C,E M. High risk HPV DNA subtypes and E6/E7 mRNA expression in a cohort of colposcopy patients from Northern Italy with high-grade histologically verified cervical lesions[J].Am J Transl Res,2012,(4):452-457.

二级参考文献26

  • 1余波光,林键,吴文言.大肠杆菌胞内的共表达策略[J].现代临床医学生物工程学杂志,2006,12(4):376-378. 被引量:2
  • 2汤晓燕,程浩,陈贤祯,张行,丁佳逸,叶俊,朱可建,岑建萍,陈萍.小干扰RNA对人乳头状瘤病毒6bE7基因表达的沉默作用[J].中华微生物学和免疫学杂志,2007,27(3):213-217. 被引量:1
  • 3McLaughlin-Drubin M E, Munger K The human papillomavirus E7 oncoprotein[J]. Virology, 2009,384: 335-344.
  • 4Halbert C L, Demers G W, Galloway D A. The E6 and E7 genes of human papillomavirus type 6 have weak immortalizing activity in human epithelial cells[J]. J Virol, 1992,66 :2125-2134.
  • 5Oh S T, Longworth M S, Laimins L A. Roles of the E6 and E7 proteins in the life cycle of low-risk human papillomavirus type II[J]. J Virol,2004,78:2620-2626.
  • 6Walboomers J M,Jacobs M V,Manos M M,et al.Hu-man papillomavirus is a necessary cause of invasive cer-vical cancer worldwide[J].J Pathol,1999,189(1):12-19.
  • 7Lin K,Doolan K,Hung C F,et al.Perspectives for preventive and therapeutic HPV vaccines[J].J Formos Med Assoc,2010,109(1):4-24.
  • 8Roden R B,Ling M,Wu T C.Vaccination to prevent and treat cervical cancer[J].Hum Pathol,2004,35(8):971-982.
  • 9Cutts F T,Franceschi S,Goldie S,et al.Human papil-lomavirus and HPV vaccines:a review.Bull World Health Organ,2007,85(9):719-726.
  • 10Bellone S,EI-Sahwi K,Cocco E,et al.Human Papillo-mavirus type16(HPV-16)virus-like particle L1-Specific CD8+cytotoxic T lymphocytes(CTLs)are equally effective as E7-specific CD8+CTLs in killing autologous HPV-16-positive tumor cells in cervical cancer patients:Implications for L1dendritic cell-based therapeutic vac-cines[J].J Virol,2009,83(13):6779-6789.

共引文献132

同被引文献48

  • 1赵超,魏丽惠.HPV疫苗的安全性问题[J].实用妇产科杂志,2010,26(3):174-177. 被引量:5
  • 2叶菁,陈广生,黄亚渝,宋宏萍,张秀敏,隋延仿.人MAGE-1基因的克隆、原核表达及其抗体的制备[J].免疫学杂志,2004,20(4):259-262. 被引量:1
  • 3高晓会,于世英,许三鹏,袁响林,徐姣珍.Celecoxib在人癌裸鼠移植瘤抗癌与放射增敏的作用机制研究[J].肿瘤防治研究,2005,32(1):4-7. 被引量:6
  • 4祁志荣,李虹.PE类重组免疫毒素的研究进展[J].微生物学免疫学进展,2006,34(1):50-53. 被引量:7
  • 5Ghose S, Allen M, Hubbard B, et al. Antibody variable re- gion interactions with protein A: implications for the devel- opment of genericpurification processes[J]. Biotechonol Bioeng, 2005, 92(6): 665-673.
  • 6Richman DD, Cleveland PH, Oxman MN, et al. The bind- ing of Staphylococcal protein A by the sera of different ani- mal species[J]. J Immunol, 1982, 128(5): 2300-2305.
  • 7Nygren PA. Alternative binding proteins: affibody binding proteins developed from a small three-helix bundle scaffold [J], FEBS J, 2008, 275(11): 2668-2676.
  • 8Nilsson B, Forsberg G, Moks T, et al. Fusionproteins in bio- thechnology and structural biology[J]. Curr Opin Biotech- nol, 1992, 2(4): 569-575.
  • 9Ljungquist C, Jansson B, Moks T, et al. Thiol-directed im- mobilization of recombinant IgG-binding receptors[J]. Eur J Biochem. 1989. 186(3:: 557-561.
  • 10Xue X1, Zhu S, Li W, et al. Identification and characteriza- tion of novel B-cell epitopes within EBV latent membrane protein 2 (LMP2)[J]. Viral Immunol, 2011, 24(3): 227-236.

引证文献7

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部